Search Press releases Keywords From To 2 Dec 2021 UCB Announces Global Partnership to Bring Disease-Modifying Therapies to People Living with Parkinson’s Disease Read More 30 Nov 2021 UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases Read More 26 Nov 2021 Disposals of own shares Read More 19 Nov 2021 Disposals of own shares Read More 19 Nov 2021 Positive Top-Line Results from BIMZELX®▼(bimekizumab) Phase 3 Psoriatic Arthritis Study Demonstrated Significant Improvements in Joint and Skin Symptoms Read More 15 Nov 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 38 Page 39 Page 40 Page 41 Current page 42 Page 43 Page 44 Page 45 Page 46 … Page 42 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe